Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 381.73 billion. The enterprise value is 387.84 billion.

Market Cap	381.73B
Enterprise Value	387.84B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Bio Plus has 56.30 million shares outstanding. The number of shares has increased by 3.20% in one year.

Current Share Class	n/a
Shares Outstanding	56.30M
Shares Change (YoY)	+3.20%
Shares Change (QoQ)	-10.78%
Owned by Insiders (%)	34.20%
Owned by Institutions (%)	6.63%
Float	36.88M

Valuation Ratios

The trailing PE ratio is 22.23.

PE Ratio	22.23
Forward PE	n/a
PS Ratio	7.23
PB Ratio	2.95
P/TBV Ratio	3.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.33, with an EV/FCF ratio of -7.71.

EV / Earnings	21.79
EV / Sales	7.25
EV / EBITDA	20.33
EV / EBIT	24.05
EV / FCF	-7.71

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.37.

Current Ratio	1.02
Quick Ratio	0.86
Debt / Equity	0.37
Debt / EBITDA	2.88
Debt / FCF	-1.09
Interest Coverage	73.57

Financial Efficiency

Return on equity (ROE) is 14.37% and return on invested capital (ROIC) is 5.90%.

Return on Equity (ROE)	14.37%
Return on Assets (ROA)	4.89%
Return on Capital (ROIC)	5.90%
Revenue Per Employee	524.30M
Profits Per Employee	174.50M
Employee Count	102
Asset Turnover	0.26
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.60% in the last 52 weeks. The beta is 0.62, so Bio Plus's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-1.60%
50-Day Moving Average	6,354.30
200-Day Moving Average	5,886.90
Relative Strength Index (RSI)	49.57
Average Volume (20 Days)	1,074,298

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 53.48 billion and earned 17.80 billion in profits. Earnings per share was 304.95.

Revenue	53.48B
Gross Profit	31.29B
Operating Income	16.13B
Pretax Income	22.76B
Net Income	17.80B
EBITDA	19.07B
EBIT	16.13B
Earnings Per Share (EPS)	304.95

Full Income Statement

Balance Sheet

The company has 69.04 billion in cash and 54.87 billion in debt, giving a net cash position of 14.18 billion or 251.81 per share.

Cash & Cash Equivalents	69.04B
Total Debt	54.87B
Net Cash	14.18B
Net Cash Per Share	251.81
Equity (Book Value)	149.75B
Book Value Per Share	2,299.46
Working Capital	1.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.03 billion and capital expenditures -79.35 billion, giving a free cash flow of -50.32 billion.

Operating Cash Flow	29.03B
Capital Expenditures	-79.35B
Free Cash Flow	-50.32B
FCF Per Share	-893.80

Full Cash Flow Statement

Margins

Gross margin is 58.52%, with operating and profit margins of 30.16% and 33.28%.

Gross Margin	58.52%
Operating Margin	30.16%
Pretax Margin	42.56%
Profit Margin	33.28%
EBITDA Margin	35.66%
EBIT Margin	30.16%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 70.00, which amounts to a dividend yield of 1.05%.

Dividend Per Share	70.00
Dividend Yield	1.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.58%
Buyback Yield	-3.20%
Shareholder Yield	-2.15%
Earnings Yield	4.50%
FCF Yield	-13.18%

Dividend Details

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 23, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio Plus has an Altman Z-Score of 3.05.

Altman Z-Score	3.05
Piotroski F-Score	n/a